# Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis

> **NCT01378182** · NA · COMPLETED · sponsor: **Murat Kantarcioglu** · enrollment: 10 (actual)

## Conditions studied

- Wilson's Disease

## Interventions

- **GENETIC:** allogeneic mesenchymal stem cell transplantation

## Key facts

- **NCT ID:** NCT01378182
- **Lead sponsor:** Murat Kantarcioglu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2013-03
- **Final completion:** 2014-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2014-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01378182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01378182, "Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01378182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*